![](/img/cover-not-exists.png)
Is daily dose of IFN plus ribavirin more effective than standard IFN plus ribavirin regimen for HCV related liver disease? A prospective randomized study
M. De Luca, A. Ascione, C. Canestrini, G.G. Di Costanzo, F.P. Picciotto, F. Lampasi, W. UtechVolume:
34
Year:
2001
Language:
english
DOI:
10.1016/s0168-8278(01)81497-5
File:
PDF, 268 KB
english, 2001